Generic Drug Maker Urges FDA To Create Incentives To Avert Shortages

December 06, 2018
To mitigate drug shortages, a not-for-profit generic drug company is proposing FDA, on its own and through collaboration with other government agencies, provide manufacturers with myriad incentives, including: reduced regulatory oversight, increased time between inspections, tax credits or federal grants, and fee waivers for certain generic companies. The company also suggests Congress fund a qualified manufacturing program at FDA along the lines of that run by the Biomedical Advanced Research and Development Authority. FDA also should create and maintain a...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.